THE PARIS® TEST
More information from living cancer cells.
The PARIS Test combines functional drug testing with molecular profiling to provide personalized information about how an individual patient’s cancer may respond to potential therapies.
WHAT IS THE PARIS TEST?
See what cancer cells actually do.
Every cancer is different. Genomic testing can identify alterations in a tumor’s DNA that may help inform treatment decisions. But genetics alone does not always reveal how an individual patient’s cancer will respond to therapy.
PARIS adds another source of information by testing living tumor cells against multiple therapies and observing their response. These functional results are considered alongside molecular information to provide a more personalized picture of the cancer.